These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9415655

  • 1. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Reiff A, Rawlings DJ, Shaham B, Franke E, Richardson L, Szer IS, Bernstein BH.
    J Rheumatol; 1997 Dec; 24(12):2436-43. PubMed ID: 9415655
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis.
    Takei S, Groh D, Bernstein B, Shaham B, Gallagher K, Reiff A.
    J Rheumatol; 2001 Jul; 28(7):1677-80. PubMed ID: 11469478
    [Abstract] [Full Text] [Related]

  • 3. [Methotrexate treatment in refractory juvenile rheumatoid arthritis].
    Brik R.
    Harefuah; 1998 Dec 01; 135(11):509-11, 567. PubMed ID: 10911466
    [Abstract] [Full Text] [Related]

  • 4. Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis.
    Ravelli A, Viola S, Ramenghi B, Aramini L, Ruperto N, Martini A.
    J Rheumatol; 1995 Aug 01; 22(8):1574-6. PubMed ID: 7473486
    [Abstract] [Full Text] [Related]

  • 5. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
    Kimura Y, Pinho P, Walco G, Higgins G, Hummell D, Szer I, Henrickson M, Watcher S, Reiff A.
    J Rheumatol; 2005 May 01; 32(5):935-42. PubMed ID: 15868633
    [Abstract] [Full Text] [Related]

  • 6. Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis.
    Wallace CA, Sherry DD.
    J Rheumatol; 1992 Oct 01; 19(10):1604-7. PubMed ID: 1464876
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate in the treatment of children with chronic arthritis--long-term observations of efficacy and safety.
    Huang JL.
    Br J Clin Pract; 1996 Sep 01; 50(6):311-4. PubMed ID: 8983319
    [Abstract] [Full Text] [Related]

  • 8. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
    Alsufyani K, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Malleson PN.
    J Rheumatol; 2004 Jan 01; 31(1):179-82. PubMed ID: 14705239
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
    Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2003 Jan 01; 48(1):218-26. PubMed ID: 12528122
    [Abstract] [Full Text] [Related]

  • 10. Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine.
    van den Borne BE, Landewé RB, Goei The HS, Rietveld JH, Zwinderman AH, Bruyn GA, Breedveld FC, Dijkmans BA.
    J Rheumatol; 1998 Aug 01; 25(8):1493-8. PubMed ID: 9712089
    [Abstract] [Full Text] [Related]

  • 11. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E, Spiegel L, Hawkins D, Petty R, Goldsmith D, Schanberg L, Duffy C, Howard P, Strand V.
    Arthritis Rheum; 2005 Feb 01; 52(2):554-62. PubMed ID: 15693001
    [Abstract] [Full Text] [Related]

  • 12. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.
    Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH, Paediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2007 Sep 01; 56(9):3096-106. PubMed ID: 17763439
    [Abstract] [Full Text] [Related]

  • 13. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.
    Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J.
    Arthritis Rheum; 2004 Apr 01; 50(4):1286-95. PubMed ID: 15077313
    [Abstract] [Full Text] [Related]

  • 14. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group.
    Giannini EH, Lovell DJ, Silverman ED, Sundel RP, Tague BL, Ruperto N.
    J Rheumatol; 1996 May 01; 23(5):919-24. PubMed ID: 8724309
    [Abstract] [Full Text] [Related]

  • 15. Musculoskeletal abnormalities of the tibia in juvenile rheumatoid arthritis.
    Felin EM, Prahalad S, Askew EW, Moyer-Mileur LJ.
    Arthritis Rheum; 2007 Mar 01; 56(3):984-94. PubMed ID: 17328076
    [Abstract] [Full Text] [Related]

  • 16. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.
    Kimura Y, Fieldston E, Devries-Vandervlugt B, Li S, Imundo L.
    J Rheumatol; 2000 Aug 01; 27(8):2018-24. PubMed ID: 10955346
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.
    Gerloni V, Pontikaki I, Gattinara M, Desiati F, Lupi E, Lurati A, Salmaso A, Fantini F.
    Arthritis Rheum; 2005 Feb 01; 52(2):548-53. PubMed ID: 15693004
    [Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of cyclosporine (Neoral) in rheumatoid arthritis.
    Johns KR, Littlejohn GO.
    J Rheumatol; 1999 Oct 01; 26(10):2110-3. PubMed ID: 10529125
    [Abstract] [Full Text] [Related]

  • 19. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, Kunkel G, Schlesinger M, Bohnsack J.
    J Clin Rheumatol; 2009 Jun 01; 15(4):161-4. PubMed ID: 19363453
    [Abstract] [Full Text] [Related]

  • 20. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis.
    Ravelli A, Di Fuccia G, Molinaro M, Ramenghi B, Zonta L, Regazzi MB, Martini A.
    J Rheumatol; 1993 Sep 01; 20(9):1573-7. PubMed ID: 8164218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.